Johnson & Johnson (JNJ) Current Assets (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Current Assets came in at $59.8 billion in Q2 2026, up 9.68% year-over-year from $54.5 billion in Q2 2025, and up 1.02% quarter-over-quarter from $59.2 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Current Assets (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Current Assets across 18 years of filings, most recently posting $59.8 billion for Q2 2026.
- In Q2 2026, Current Assets rose 9.68% year-over-year to $59.8 billion; the TTM figure through Jun 2026 stood at $59.8 billion (up 9.68% YoY), while the FY2025 annual figure was $55.6 billion, changed 0.48% from the prior year.
- Current Assets came in at $59.8 billion for Q2 2026 at Johnson & Johnson, up from $59.2 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $71.6 billion in Q1 2025 to a low of $53.2 billion in Q3 2024.
- Average Current Assets over 5 years is $58.8 billion, with a median of $57.8 billion recorded in 2024.
- Year-over-year, Current Assets declined 17.68% in 2023 and advanced 25.52% in 2025.
- Over 5 years, Current Assets stood at $65.2 billion in 2022, then fell by 18.0% to $53.5 billion in 2023, then increased by 4.48% to $55.9 billion in 2024, then fell by 0.48% to $55.6 billion in 2025, then gained by 7.46% to $59.8 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $59.8 billion in Q2 2026, $59.2 billion in Q1 2026, and $55.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 4.03 Bn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 3.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 59.77 Bn |
| Mar 29, 2026 | 59.17 Bn |
| Dec 28, 2025 | 55.62 Bn |
| Sep 28, 2025 | 54.61 Bn |
| Jun 29, 2025 | 54.50 Bn |
| Mar 30, 2025 | 71.55 Bn |
| Dec 29, 2024 | 55.89 Bn |
| Sep 29, 2024 | 53.25 Bn |
| Jun 30, 2024 | 57.82 Bn |
| Mar 31, 2024 | 57.00 Bn |
| Dec 31, 2023 | 53.50 Bn |
| Oct 1, 2023 | 53.70 Bn |
| Jul 2, 2023 | 60.57 Bn |
| Apr 2, 2023 | 64.39 Bn |
| Jan 1, 2023 | 55.29 Bn |
| Oct 2, 2022 | 65.24 Bn |
| Jul 3, 2022 | 63.85 Bn |
| Apr 3, 2022 | 60.42 Bn |
| Jan 2, 2022 | 60.98 Bn |
| Oct 3, 2021 | 59.89 Bn |